news

21/09/2017

HRA Pharma completes acquisition of Compeed®
27/07/2017

HRA Pharma signs agreement to acquire the Compeed® brand from CILAG GmbH International
03/07/2017

HRA Pharma appoints Martyn Hilton as Global Commercial Director
26/06/2017

Restricted access to emergency contraception in Poland is a backwards step for women’s reproductive health rights
12/06/2017

Ulipristal acetate for Emergency Contraception to be included on the Essential Medicines List by the World Health Organization

Media

news & press releases

filter by theme

< 1 2 3 4 5 6 7 8 9 10 11 >

October 2009

HRA Pharma Launches ellaOne® in Europe.

September 2009

HRA Pharma Announces European Marketing and Distribution Agreement with Acrux.

September 2009

HRA Pharma Named Finalist for the 2009 Scrip Awards and the 2009 Clinical Research Excellence Awards.

September 2009

HRA Pharma Reinforces Operational Presence in Europe with Italian Subsid

July 2009

HRA Pharma Marks Next Step in European Expansion with UK Subsidiary.

June 2009

NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada.

May 2009

HRA Pharma Granted European Marketing Authorization for ellaOne®.

May 2009

HRA Pharma and Preglem Announce Successful Completion of Phase IIB for Ulipristal Acetate for the Treatment of Uterine Fibroids.

filter by theme

< 1 2 3 4 5 6 7 8 9 10 11 >

you are leaving hra pharma

You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?

YES